$UAVS
AgEagle Aerial Systems Inc. Stock $uavs

$uavs Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000149315223028560 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$3.484M	$3.278M	$5.288M
YoY Change	-36.55%	-38.01%	172.94%
Cost Of Revenue	$2.270M	$2.247M	$2.738M
YoY Change	-33.39%	-17.94%	185.41%
Gross Profit	$1.214M	$1.032M	$2.550M
YoY Change	-41.72%	-59.55%	160.71%
Gross Profit Margin	34.85%	31.47%	48.23%
Selling, General & Admin	$4.336M	$4.455M	$5.756M
YoY Change	-19.88%	-22.61%	17.68%
% of Gross Profit	357.13%	431.84%	225.73%
Research & Development	$1.368M	$1.369M	$2.182M
YoY Change	-24.75%	-37.25%	140.61%
% of Gross Profit	112.71%	132.76%	85.58%
Depreciation & Amortization	$93.61K	$99.23K	$114.4K
YoY Change	-15.03%	-13.27%	233.34%
% of Gross Profit	7.71%	9.62%	4.49%
Operating Expenses	$7.204M	$5.903M	$7.939M
YoY Change	-0.36%	-25.64%	36.91%
Operating Profit	-$5.990M	-$4.872M	-$5.389M
YoY Change	16.37%	-9.59%	11.78%
Interest Expense	$84.44K	-$289.6K	-$213.2K
YoY Change	-1354.73%	35.86%	-3560.39%
% of Operating Profit
Other Income/Expense, Net	-$2.030M	-$418.7K	-$213.2K
YoY Change	-129.8%	96.45%	-249.78%
Pretax Income	-$8.020M	-$5.291M	-$5.602M
YoY Change	-581.7%	-5.55%	19.74%
Income Tax
% Of Pretax Income
Net Earnings	-$8.020M	-$5.291M	-$5.602M
YoY Change	-581.7%	-5.55%	19.74%
Net Earnings / Revenue	-230.2%	-161.39%	-105.94%
Basic Earnings Per Share	-$0.07	-$0.05	-$0.07
Diluted Earnings Per Share	-$0.07	-$0.05	-$68.60K
COMMON SHARES
Basic Shares Outstanding	109.5M shares	91.07M shares	81.66M shares
Diluted Shares Outstanding	111.1M shares	96.22M shares	81.66M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.600M	$4.202M	$13.51M
YoY Change	-69.83%	-68.88%	-65.56%
Cash & Equivalents	$1.600M	$4.202M	$13.51M
Short-Term Investments
Other Short-Term Assets	$800.0K	$901.1K	$2.122M
YoY Change	-33.86%	-57.54%	204.05%
Inventory	$6.064M	$6.520M	$5.648M
Prepaid Expenses	$832.2K	$901.1K	$2.122M
Receivables	$2.015M	$2.103M	$3.763M
Other Receivables	$200.0K	$185.0K	$185.0K
Total Short-Term Assets	$10.70M	$13.91M	$25.22M
YoY Change	-33.12%	-44.85%	-40.31%
LONG-TERM ASSETS
Property, Plant & Equipment	$598.0K	$651.0K	$842.7K
YoY Change	-28.65%	-22.75%	-42.95%
Goodwill	$21.68M	$23.18M	$64.87M
YoY Change	-66.58%	-64.27%
Intangibles	$9.243M	$10.07M	$12.88M
YoY Change	-24.35%	-21.82%
Long-Term Investments
YoY Change
Other Assets	$300.0K	$354.3K	$284.0K
YoY Change	7.21%	24.76%	1036.08%
Total Long-Term Assets	$35.35M	$37.80M	$80.31M
YoY Change	-55.45%	-52.93%	11.1%
TOTAL ASSETS
Total Short-Term Assets	$10.70M	$13.91M	$25.22M
Total Long-Term Assets	$35.35M	$37.80M	$80.31M
Total Assets	$46.05M	$51.71M	$105.5M
YoY Change	-51.7%	-51.0%	-7.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.126M	$1.502M	$2.159M
YoY Change	-3.12%	-30.4%	87.48%
Accrued Expenses	$2.500M	$2.384M
YoY Change	1057.88%
Deferred Revenue	$329.5K	$440.2K	$2.133M
YoY Change	-49.55%	-79.36%
Short-Term Debt	$2.600M	$1.590M	$0.00
YoY Change
Long-Term Debt Due	$300.0K	$458.4K	$604.1K
YoY Change	-21.12%	-24.11%
Total Short-Term Liabilities	$7.878M	$6.375M	$16.45M
YoY Change	36.5%	-61.25%	100.87%
LONG-TERM LIABILITIES
Long-Term Debt	$509.2K	$417.3K	$604.4K
YoY Change	-19.72%	-30.96%
Other Long-Term Liabilities	$2.800M	$2.843M	$4.877M
YoY Change	324.08%	-41.71%	-57.43%
Total Long-Term Liabilities	$509.2K	$417.3K	$604.4K
YoY Change	-19.72%	-30.96%	-94.72%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.878M	$6.375M	$16.45M
Total Long-Term Liabilities	$509.2K	$417.3K	$604.4K
Total Liabilities	$12.61M	$10.53M	$21.93M
YoY Change	78.51%	-51.98%	11.63%
SHAREHOLDERS EQUITY
Retained Earnings	-$134.4M	-$126.4M	-$64.25M
YoY Change	114.7%	96.65%
Common Stock	$117.9K	$109.5K	$82.45K
YoY Change	34.8%	32.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$33.44M	$41.18M	$83.60M
YoY Change
Total Liabilities & Shareholders Equity	$46.05M	$51.71M	$105.5M
YoY Change	-51.7%	-51.0%	-7.87%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$8.020M	-$5.291M	-$5.602M
YoY Change	-581.7%	-5.55%	19.74%
Depreciation, Depletion And Amortization	$93.61K	$99.23K	$114.4K
YoY Change	-15.03%	-13.27%	233.34%
Cash From Operating Activities	-$2.050M	-$2.549M	-$5.118M
YoY Change	-44.8%	-50.2%	115.24%
INVESTING ACTIVITIES
Capital Expenditures	$50.00K	$42.77K	-$62.20K
YoY Change	-144.16%	-168.76%	-51.25%
Acquisitions
YoY Change
Other Investing Activities	-$90.00K	-$127.4K	-$438.7K
YoY Change	-97.72%	-70.96%	-96.07%
Cash From Investing Activities	-$140.0K	-$170.1K	-$500.9K
YoY Change	-96.55%	-66.03%	-95.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-50.00K	3.776M	9.951M
YoY Change	-489.11%	-62.05%	-65.31%
NET CHANGE
Cash From Operating Activities	-2.050M	-2.549M	-5.118M
Cash From Investing Activities	-140.0K	-170.1K	-500.9K
Cash From Financing Activities	-50.00K	3.776M	9.951M
Net Change In Cash	-2.240M	1.058M	4.332M
YoY Change	-71.13%	-75.59%	-71.16%
FREE CASH FLOW
Cash From Operating Activities	-$2.050M	-$2.549M	-$5.118M
Capital Expenditures	$50.00K	$42.77K	-$62.20K
Free Cash Flow	-$2.100M	-$2.592M	-$5.056M
YoY Change	-41.68%	-48.74%	124.69%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000008504
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2023Q2	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	UAVS	Accrued Dividends On Series F Preferred Stock AccruedDividendsOnSeriesFPreferredStock		usd
	UAVS	Accrued Dividends On Series F Preferred Stock AccruedDividendsOnSeriesFPreferredStock		usd
CY2022Q2	UAVS	Deemed Dividends On Series F Preferred Stock DeemedDividendsOnSeriesFPreferredStock		usd
	UAVS	Deemed Dividends On Series F Preferred Stock DeemedDividendsOnSeriesFPreferredStock		usd
CY2023Q2	UAVS	Conversion Of Preferred Stock Series F Convertible Shares To Common Stock Amount ConversionOfPreferredStockSeriesFConvertibleSharesToCommonStockAmount		usd
CY2023Q2	UAVS	Deemed Dividend On Series F Preferred Stock And Warrants DeemedDividendOnSeriesFPreferredStockAndWarrants		usd
	UAVS	Conversion Of Preferred Stock Series F Convertible Shares To Common Stock Amount ConversionOfPreferredStockSeriesFConvertibleSharesToCommonStockAmount		usd
	UAVS	Stock Issued During Period Value Deemed Dividend On Series F Preferred Stock And Warrant StockIssuedDuringPeriodValueDeemedDividendOnSeriesFPreferredStockAndWarrant		usd
CY2022Q2	UAVS	Conversion Of Preferred Stock Series F Convertible Shares To Common Stock Amount ConversionOfPreferredStockSeriesFConvertibleSharesToCommonStockAmount		usd
CY2022Q2	UAVS	Stock Issued During Period Value Issuance Of Restricted Common Stock StockIssuedDuringPeriodValueIssuanceOfRestrictedCommonStock		usd
	UAVS	Stock Issued During Period Value Issuance Of Restricted Common Stock StockIssuedDuringPeriodValueIssuanceOfRestrictedCommonStock		usd
	UAVS	Conversion Of Preferred Stock Series F Convertible Shares To Common Stock Amount ConversionOfPreferredStockSeriesFConvertibleSharesToCommonStockAmount		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss		usd
	UAVS	Acquisition Of Sensefly Net Of Cash Acquired AcquisitionOfSenseflyNetOfCashAcquired		usd
	UAVS	Acquisition Of Micasense Net Of Cash Acquired AcquisitionOfMicasenseNetOfCashAcquired		usd
	UAVS	Covid Loans CovidLoans		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	UAVS	Issuance Of Restricted Common Stock IssuanceOfRestrictedCommonStock		usd
	UAVS	Dividends On Preferred Stock Series F DividendsOnPreferredStockSeriesF		usd
	UAVS	Deemed Dividend On Series F Preferred Stock And Warrant DeemedDividendOnSeriesFPreferredStockAndWarrant		usd
	UAVS	Stock Consideration For Sensefly Acquisition StockConsiderationForSenseflyAcquisition		usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	UAVS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercised Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-36492
	dei	Entity Registrant Name EntityRegistrantName	AGEAGLE AERIAL SYSTEMS INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	88-0422242
	dei	Entity Address Address Line1 EntityAddressAddressLine1	8863 E. 34th Street North
	dei	Entity Address City Or Town EntityAddressCityOrTown	Wichita
	dei	Entity Address State Or Province EntityAddressStateOrProvince	KS
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	67226
	dei	City Area Code CityAreaCode	(620)
	dei	Local Phone Number LocalPhoneNumber	325-6363
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	UAVS
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	109512375	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4202427	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4349837	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2103120	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2213040	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	6520314	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6685847	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	901143	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1029548	usd
CY2023Q2	us-gaap	Notes Receivable Net NotesReceivableNet	185000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	185000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	13912004	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	14463272	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	650990	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	791155	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3546549	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3952317	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10069558	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11507653	usd
CY2023Q2	us-gaap	Goodwill Goodwill	23179411	usd
CY2022Q4	us-gaap	Goodwill Goodwill	23179411	usd
CY2023Q2	us-gaap	Other Assets OtherAssets	354339	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	291066	usd
CY2023Q2	us-gaap	Assets Assets	51712851	usd
CY2022Q4	us-gaap	Assets Assets	54184874	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1502463	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1845135	usd
CY2023Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1582153	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1680706	usd
CY2023Q2	UAVS	Promissory Note Net Of Debt Discount PromissoryNoteNetOfDebtDiscount	1589660	usd
CY2022Q4	UAVS	Promissory Note Net Of Debt Discount PromissoryNoteNetOfDebtDiscount	287381	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	440165	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	496390	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	801887	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	628113	usd
CY2023Q2	UAVS	Current Portion Of Covid Loan CurrentPortionOfCovidLoan	458422	usd
CY2022Q4	UAVS	Current Portion Of Covid Loan CurrentPortionOfCovidLoan	446456	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	6374750	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5384181	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2842944	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3161703	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	417296	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	446813	usd
CY2022Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	106163	usd
CY2023Q2	UAVS	Long Term Portion Of Promissory Note Net Of Debt Discount LongTermPortionOfPromissoryNoteNetOfDebtDiscount	897031	usd
CY2022Q4	UAVS	Long Term Portion Of Promissory Note Net Of Debt Discount LongTermPortionOfPromissoryNoteNetOfDebtDiscount	1861539	usd
CY2023Q2	us-gaap	Liabilities Liabilities	10532021	usd
CY2022Q4	us-gaap	Liabilities Liabilities	10960399	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	7	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	6	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	7	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	6	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	109491375	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	109491375	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	88466613	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	88466613	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	109492	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	88467	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	167247840	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	154679363	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-126354420	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-111553444	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	177911	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	10083	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	41180830	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	43224475	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	51712851	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54184874	usd
CY2023Q2	us-gaap	Revenues Revenues	3278212	usd
CY2022Q2	us-gaap	Revenues Revenues	5287873	usd
	us-gaap	Revenues Revenues	7335281	usd
	us-gaap	Revenues Revenues	9129851	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	2246678	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	2737777	usd
	us-gaap	Cost Of Revenue CostOfRevenue	4325115	usd
	us-gaap	Cost Of Revenue CostOfRevenue	5214863	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	1031534	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	2550096	usd
	us-gaap	Gross Profit GrossProfit	3010166	usd
	us-gaap	Gross Profit GrossProfit	3914988	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3498761	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4437185	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7078283	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9918564	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1369479	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2182313	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2951822	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4367237	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	955845	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1319177	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1933720	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2499706	usd
CY2023Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	79287	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	79287	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	5903372	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	7938675	usd
	us-gaap	Operating Expenses OperatingExpenses	12043112	usd
	us-gaap	Operating Expenses OperatingExpenses	16785507	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4871838	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5388579	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9032946	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12870519	usd
CY2023Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-289604	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-6719	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-595101	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-23051	usd
CY2023Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-129141	usd
CY2022Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-206438	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-262035	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-304738	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-418745	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-213157	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-857136	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-327789	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5290583	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5601736	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9890082	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13198308	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-5290583	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5601736	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9890082	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13198308	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	96217930	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	96217930	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81659858	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81659858	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	92922549	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	92922549	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79732890	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79732890	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	96217930	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81659858	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	92922549	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79732890	shares
CY2023Q2	UAVS	Net Loss Attributable To Common Stockholders NetLossAttributableToCommonStockholders	-5290583	usd
CY2022Q2	UAVS	Net Loss Attributable To Common Stockholders NetLossAttributableToCommonStockholders	-5601736	usd
	UAVS	Net Loss Attributable To Common Stockholders NetLossAttributableToCommonStockholders	-9890082	usd
	UAVS	Net Loss Attributable To Common Stockholders NetLossAttributableToCommonStockholders	-13198308	usd
CY2023Q2	UAVS	Amortization Of Unrecognized Periodic Pension Costs1 AmortizationOfUnrecognizedPeriodicPensionCosts1	-699	usd
CY2022Q2	UAVS	Amortization Of Unrecognized Periodic Pension Costs1 AmortizationOfUnrecognizedPeriodicPensionCosts1	-2641	usd
	UAVS	Amortization Of Unrecognized Periodic Pension Costs1 AmortizationOfUnrecognizedPeriodicPensionCosts1	-44044	usd
	UAVS	Amortization Of Unrecognized Periodic Pension Costs1 AmortizationOfUnrecognizedPeriodicPensionCosts1	-2641	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	-72525	usd
CY2022Q2	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	-132136	usd
	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	-123784	usd
	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	-152308	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5217359	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5466959	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9722254	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13043359	usd
CY2023Q2	UAVS	Accrued Dividends On Series F Preferred Stock AccruedDividendsOnSeriesFPreferredStock	-54234	usd
	UAVS	Accrued Dividends On Series F Preferred Stock AccruedDividendsOnSeriesFPreferredStock	-121156	usd
CY2023Q2	UAVS	Deemed Dividends On Series F Preferred Stock DeemedDividendsOnSeriesFPreferredStock	-4654918	usd
	UAVS	Deemed Dividends On Series F Preferred Stock DeemedDividendsOnSeriesFPreferredStock	-4910894	usd
CY2023Q2	UAVS	Total Comprehensive Loss Available To Common Stockholders TotalComprehensiveLossAvailableToCommonStockholders	-9926511	usd
CY2022Q2	UAVS	Total Comprehensive Loss Available To Common Stockholders TotalComprehensiveLossAvailableToCommonStockholders	-5466959	usd
	UAVS	Total Comprehensive Loss Available To Common Stockholders TotalComprehensiveLossAvailableToCommonStockholders	-14754304	usd
	UAVS	Total Comprehensive Loss Available To Common Stockholders TotalComprehensiveLossAvailableToCommonStockholders	-13043359	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	42165188	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3817400	usd
CY2023Q2	UAVS	Dividends On Series F Preferred Stock DividendsOnSeriesFPreferredStock	-54234	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	469835	usd
CY2023Q2	UAVS	Amortization Of Unrecognized Periodic Pension Costs AmortizationOfUnrecognizedPeriodicPensionCosts	699	usd
CY2023Q2	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	72525	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-5290583	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	41180830	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	43224475	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3817400	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	3000000	usd
	UAVS	Dividends On Series F Preferred Stock DividendsOnSeriesFPreferredStock	-121156	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	982365	usd
	UAVS	Amortization Of Unrecognized Periodic Pension Costs AmortizationOfUnrecognizedPeriodicPensionCosts	44044	usd
	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	123784	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9890082	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	41180830	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	78368485	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	9920000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	30750	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	748023	usd
CY2022Q2	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	132136	usd
CY2022Q2	UAVS	Amortization Of Unrecognized Periodic Pension Costs AmortizationOfUnrecognizedPeriodicPensionCosts	2641	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5601736	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	83600299	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	76576913	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4583341	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	3000000	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	9920000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	61500	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2501904	usd
	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	152308	usd
	UAVS	Amortization Of Unrecognized Periodic Pension Costs AmortizationOfUnrecognizedPeriodicPensionCosts	2641	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13198308	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	83600299	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	83600299	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9890082	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13198308	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	982365	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2501904	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2014256	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1844196	usd
	UAVS	Defined Benefit Plan Obligation And Other DefinedBenefitPlanObligationAndOther	-197649	usd
	UAVS	Defined Benefit Plan Obligation And Other DefinedBenefitPlanObligationAndOther	-5644	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	337770	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	79287	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-132005	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	944064	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-259406	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1702158	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-174320	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	846691	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-365772	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-348416	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-54136	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-290443	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-60191	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1168007	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-194899	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	193528	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6783320	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11628089	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	48107	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	137149	usd
	UAVS	Acquisition Of Sensefly Net Of Cash Acquired AcquisitionOfSenseflyNetOfCashAcquired	489989	usd
	UAVS	Acquisition Of Micasense Net Of Cash Acquired AcquisitionOfMicasenseNetOfCashAcquired	2446512	usd
	UAVS	Capitalization Of Platform Development Costs CapitalizationOfPlatformDevelopmentCosts	232441	usd
	UAVS	Capitalization Of Platform Development Costs CapitalizationOfPlatformDevelopmentCosts	319799	usd
	us-gaap	Payments For Software PaymentsForSoftware	143796	usd
	us-gaap	Payments For Software PaymentsForSoftware	610643	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-424344	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4004092	usd
	UAVS	Sales Of Common Stock Net Of Issuance Cost1 SalesOfCommonStockNetOfIssuanceCost1	3817400	usd
	UAVS	Sales Of Common Stock Net Of Issuance Cost1 SalesOfCommonStockNetOfIssuanceCost1	4583341	usd
	UAVS	Sale Of Preferred Stock Series F Net Of Issuance Costs SaleOfPreferredStockSeriesFNetOfIssuanceCosts	3000000	usd
	UAVS	Sale Of Preferred Stock Series F Net Of Issuance Costs SaleOfPreferredStockSeriesFNetOfIssuanceCosts	9920000	usd
	UAVS	Covid Loans CovidLoans	40927	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	61500	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6776473	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14564841	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	283781	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-17633	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-147410	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1084973	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4349837	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14590566	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4202427	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13505593	usd
	UAVS	Conversion Of Preferred Stock Series F To Common Stock ConversionOfPreferredStockSeriesFToCommonStock	4305	usd
	UAVS	Conversion Of Preferred Stock Series F To Common Stock ConversionOfPreferredStockSeriesFToCommonStock	500	usd
	UAVS	Issuance Of Restricted Common Stock IssuanceOfRestrictedCommonStock	302	usd
	UAVS	Dividends On Preferred Stock Series F DividendsOnPreferredStockSeriesF	121155	usd
	UAVS	Deemed Dividend On Series F Preferred Stock And Warrant DeemedDividendOnSeriesFPreferredStockAndWarrant	4910894	usd
	UAVS	Stock Consideration For Sensefly Acquisition StockConsiderationForSenseflyAcquisition	3000000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9890082	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6783320	usd
CY2023Q2	UAVS	Working Capital WorkingCapital	7537254	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-126354420	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_zNzHk6I4V7Ni" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_zG0WJRQbliRi">Use of Estimates</span> </i>– The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the reserve for obsolete inventory, valuation of stock issued for services and stock options, valuation of intangible assets, and the valuation of deferred tax assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	250000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	440165	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	496390	usd
CY2023Q2	UAVS	Capitalized Software Development Costs For Internaluse Software CapitalizedSoftwareDevelopmentCostsForInternaluseSoftware	699404	usd
CY2022Q4	UAVS	Capitalized Software Development Costs For Internaluse Software CapitalizedSoftwareDevelopmentCostsForInternaluseSoftware	721795	usd
CY2023Q2	us-gaap	Goodwill Goodwill	23179411	usd
CY2022Q4	us-gaap	Goodwill Goodwill	23179411	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10069558	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11507653	usd
CY2023Q2	UAVS	Shipping Costs ShippingCosts	57545	usd
CY2022Q2	UAVS	Shipping Costs ShippingCosts	85516	usd
	UAVS	Shipping Costs ShippingCosts	122481	usd
	UAVS	Shipping Costs ShippingCosts	144975	usd
CY2023Q2	us-gaap	Advertising Expense AdvertisingExpense	27729	usd
CY2022Q2	us-gaap	Advertising Expense AdvertisingExpense	103756	usd
	us-gaap	Advertising Expense AdvertisingExpense	68418	usd
	us-gaap	Advertising Expense AdvertisingExpense	164382	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2103120	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2213040	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1494896	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	912376	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	2120217	usd
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	2229840	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	17097	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	16800	usd
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	4451551	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	5288206	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	849645	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1106056	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1546566	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	614400	usd
CY2023Q2	us-gaap	Inventory Gross InventoryGross	6847762	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	7008662	usd
CY2023Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	327448	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	322815	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	6520314	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6685847	usd
CY2023Q2	us-gaap	Supplies Supplies	208538	usd
CY2022Q4	us-gaap	Supplies Supplies	281484	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	326851	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	184429	usd
CY2023Q2	us-gaap	Prepaid Rent PrepaidRent	131537	usd
CY2022Q4	us-gaap	Prepaid Rent PrepaidRent	234691	usd
CY2023Q2	us-gaap	Prepaid Insurance PrepaidInsurance	85107	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	167794	usd
CY2023Q2	us-gaap	Prepaid Taxes PrepaidTaxes	57373	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	99558	usd
CY2023Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	91737	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	61592	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	901143	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1029548	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1563366	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	703741	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	650990	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	791155	usd
CY2023Q2	us-gaap	Depreciation Depreciation	99227	usd
CY2022Q2	us-gaap	Depreciation Depreciation	114404	usd
	us-gaap	Depreciation Depreciation	199924	usd
	us-gaap	Depreciation Depreciation	225139	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11507653	usd
	us-gaap	Finite Lived Intangible Assets Period Increase Decrease FiniteLivedIntangibleAssetsPeriodIncreaseDecrease	376237	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1814332	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10069558	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P4Y3M25D
CY2023Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	913691	usd
CY2022Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	851284	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1814332	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	288065	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1723910	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2818215	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1589173	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1197817	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1158057	usd
CY2023Q2	UAVS	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	1582386	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10069558	usd
CY2023Q2	UAVS	Accrued Purchases And Customer Deposits AccruedPurchasesAndCustomerDeposits	315197	usd
CY2022Q4	UAVS	Accrued Purchases And Customer Deposits AccruedPurchasesAndCustomerDeposits	102319	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	299445	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	774916	usd
CY2023Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	296055	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	288807	usd
CY2023Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	293751	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	172596	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	160222	usd
CY2023Q2	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	158485	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	262737	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	58998	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	79331	usd
CY2023Q2	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	1582153	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	1680706	usd
CY2021Q4	UAVS	Good Faith Acquisition Ofconsideration GoodFaithAcquisitionOfconsideration	15000000	usd
	UAVS	Covid Loan Disclosuretext Block CovidLoanDisclosuretextBlock	<p id="xdx_80B_ecustom--CovidLoanDisclosuretextBlock_zUULepUN9Ykf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 5 – <span id="xdx_829_zdVwUA7gjiz5">COVID Loans</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the senseFly Acquisition, the Company assumed the obligations for two COVID Loans originally made by the SBA to senseFly S.A. on July 27, 2020 (“senseFly COVID Loans”). As of senseFly Acquisition Date, the fair value of the COVID Loan was $<span id="xdx_907_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_iI_c20230630__us-gaap--BusinessAcquisitionAxis__custom--SenseflyMember_z8OTz3Fw82Bf" title="Fair value of the covid loan">1,440,046</span> (“senseFly COVID Loans”). For the three and six months ended June 30, 2023, senseFly S.A. made the required payments on the senseFly COVID Loans, including principal and accrued interest, aggregating approximately $<span id="xdx_909_eus-gaap--RepaymentsOfDebt_c20230401__20230630__us-gaap--DebtInstrumentAxis__custom--SenseflyMember_zfMPgwBn6id5" title="Payment of principal and interest"><span id="xdx_903_eus-gaap--RepaymentsOfDebt_c20230101__20230630__us-gaap--DebtInstrumentAxis__custom--SenseflyMember_z5DG9Ytv5eu4" title="Payment of principal and interest">40,927</span></span>, for the three and six months ended June 30, 2023, respectively, <span id="xdx_909_eus-gaap--RepaymentsOfDebt_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--SenseflyMember_zGGqR0LpTGPb" title="Payment of principal and interest"><span id="xdx_90F_eus-gaap--RepaymentsOfDebt_c20220401__20220630__us-gaap--DebtInstrumentAxis__custom--SenseflyMember_zNiLcOBOaQbk" title="Payment of principal and interest">no</span></span> payments of principal and interest were required. As of June 30, 2023, the Company’s outstanding obligations under the senseFly COVID Loans are $<span id="xdx_90C_eus-gaap--DebtInstrumentCarryingAmount_iI_c20230630__us-gaap--DebtInstrumentAxis__custom--SenseflyCovidLoansMember_zVrN6PlhD2wl" title="Outstanding obligations under the covid loans">875,718</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zdT1hCFkzqpa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, scheduled principal payments due under the senseFly COVID Loans are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_z4RyovIDmXa1" style="display: none">Schedule of Maturity of SenseFly Covid Loans</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="font-weight: bold"> </td><td> </td> <td colspan="2" id="xdx_497_20230630_zWopQsZtaNT7"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Year ending December 31,</td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_403_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_iI_zNS7siwe2ma5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%">2023 (rest of year)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">416,931</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_z8FhpeYGr5a8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">91,758</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_zl9ZCsc16JP9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">91,758</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_zMl8vKJPHFg1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">91,758</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_zWBKjkSdifP9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">2027</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">183,512</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LongTermDebt_iI_zo3DUO986DZ3" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">875,718</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zN51gfuAur4c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	416931	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	91758	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	91758	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	91758	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	183512	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	875718	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	3500000	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5000000	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.44
CY2022Q4	UAVS	Debt Instrument Original Issue Discount Percent DebtInstrumentOriginalIssueDiscountPercent	0.04	pure
CY2022Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.08	pure
CY2022Q4	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	3285000	usd
CY2022Q4	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	140000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	75000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1847200	usd
	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	1182349	usd
	UAVS	Debt Instrument Discount Including Fair Value Of Warrants DebtInstrumentDiscountIncludingFairValueOfWarrants	1397350	usd
CY2023Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	168885	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	337770	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	1013309	usd
CY2022Q2	us-gaap	Investments In And Advances To Affiliates At Fair Value Gross Additions InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions	3300000	usd
CY2023Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	70778	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	160222	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	160222	usd
CY2023Q2	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	3500000	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	1013309	usd
CY2023Q2	us-gaap	Compensating Balance Amount CompensatingBalanceAmount	2486691	usd
CY2023Q2	UAVS	Percentage Of Aggregate Of The Offered Securities PercentageOfAggregateOfTheOfferedSecurities	0.50	pure
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	UAVS	Description Of Down Round Or Anti Dilution Trigger Event DescriptionOfDownRoundOrAntiDilutionTriggerEvent	a down round or anti-dilution trigger event occurred resulting in the conversion rate on the Series F and the exercise price of the Series F Warrants issued with the Series F adjusting down to $0.44 from $0.62 and $0.96, respectively (the “December Down Round Trigger”)
	UAVS	Aggregate Deemed Dividend AggregateDeemedDividend	2245377	usd
CY2023Q1	UAVS	Aggregate Deemed Dividend AggregateDeemedDividend	255976	usd
CY2023Q2	UAVS	Aggregate Deemed Dividend AggregateDeemedDividend	4654918	usd
CY2023Q2	us-gaap	Dividends Dividends	54234	usd
	us-gaap	Dividends Dividends	121155	usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	1000	usd
	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.05	pure
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	469835	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	982365	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	748023	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2501904	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	644969	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	527699	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2561231	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.18
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.19
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y3M29D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	31124	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	275000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.35
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.16
	UAVS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Granted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted	P3Y7D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	57249	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	5.73
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	3.08
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2778982	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.93
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.05
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y3D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	9750	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2232641	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.26
CY2023Q2	UAVS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue	1.23
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y7M24D
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	9750	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2541667	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.88
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.57
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y3M7D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1244029	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	260000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.91
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.43
	UAVS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Granted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted	P3Y7D
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	150000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.41
	UAVS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercised Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue	0.30
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	35415	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	199419	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	6.11
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	3.28
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2452248	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.56
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.39
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y7M9D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	240897	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1759030	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.36
CY2022Q2	UAVS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue	1.30
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y4M2D
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	240897	usd
CY2023Q2	us-gaap	Share Price SharePrice	0.35
CY2022Q2	us-gaap	Share Price SharePrice	0.65
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y7D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y7D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	64.37	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	69.91	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	4.12	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	2.73	pure
	UAVS	Operating Leases Rent Expense Sublease Rentals OperatingLeasesRentExpenseSubleaseRentals	433137	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	79287	usd
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	13356	usd
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	264430	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	528343	usd
CY2022Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	628449	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	961922	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3546549	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3952317	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	801887	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	628113	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2842944	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3161703	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	512380	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	964671	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	970744	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	762255	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	743301	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	185825	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	4139176	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	494345	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3644831	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	801887	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2842944	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-213157	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5601736	usd
	us-gaap	Revenues Revenues	7335281	usd
	us-gaap	Cost Of Revenue CostOfRevenue	4325115	usd
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y4M24D
CY2022	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y9M18D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.060	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.060	pure
CY2023Q2	UAVS	Cash Paid For Amounts Included In Measurement Of Liabilities Operating Cash Flows For Operating Leases CashPaidForAmountsIncludedInMeasurementOfLiabilitiesOperatingCashFlowsForOperatingLeases	264430	usd
CY2022Q2	UAVS	Cash Paid For Amounts Included In Measurement Of Liabilities Operating Cash Flows For Operating Leases CashPaidForAmountsIncludedInMeasurementOfLiabilitiesOperatingCashFlowsForOperatingLeases	628449	usd
	UAVS	Cash Paid For Amounts Included In Measurement Of Liabilities Operating Cash Flows For Operating Leases CashPaidForAmountsIncludedInMeasurementOfLiabilitiesOperatingCashFlowsForOperatingLeases	528343	usd
	UAVS	Cash Paid For Amounts Included In Measurement Of Liabilities Operating Cash Flows For Operating Leases CashPaidForAmountsIncludedInMeasurementOfLiabilitiesOperatingCashFlowsForOperatingLeases	961922	usd
CY2023Q1	us-gaap	Additional Liability Long Duration Insurance Gross Premium Income AdditionalLiabilityLongDurationInsuranceGrossPremiumIncome	3000000	usd
CY2023Q2	us-gaap	Other Commitment OtherCommitment	2377378	usd
CY2022Q4	us-gaap	Other Commitment OtherCommitment	3155867	usd
CY2023Q2	us-gaap	Goodwill Goodwill	23179411	usd
CY2023Q2	us-gaap	Assets Assets	51712851	usd
CY2022Q4	us-gaap	Goodwill Goodwill	23179411	usd
CY2022Q4	us-gaap	Assets Assets	54184874	usd
CY2023Q2	us-gaap	Revenues Revenues	3278212	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	2246678	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4871838	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-418745	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-5290583	usd
CY2022Q2	us-gaap	Revenues Revenues	5287873	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	2737777	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5388579	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9032946	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-857136	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9890082	usd
	us-gaap	Revenues Revenues	9129851	usd
	us-gaap	Cost Of Revenue CostOfRevenue	5214863	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12870519	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-327789	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13198308	usd
CY2023Q2	us-gaap	Revenues Revenues	3278212	usd
CY2022Q2	us-gaap	Revenues Revenues	5287873	usd
	us-gaap	Revenues Revenues	7335281	usd
	us-gaap	Revenues Revenues	9129851	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	525000	usd

Files In Submission

Name	View Source	Status
form10-q_htm.xml	Edgar Link	completed
0001493152-23-028560-index-headers.html	Edgar Link	pending
0001493152-23-028560-index.html	Edgar Link	pending
0001493152-23-028560.txt	Edgar Link	pending
0001493152-23-028560-xbrl.zip	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
uavs-20230630.xsd	Edgar Link	pending
uavs-20230630_def.xml	Edgar Link	unprocessable
uavs-20230630_lab.xml	Edgar Link	unprocessable
uavs-20230630_cal.xml	Edgar Link	unprocessable
uavs-20230630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$UAVS
AgEagle Aerial Systems Inc. Stock $uavs

2023 Q3 Form 10-Q Financial Statement

#000149315223028560 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UAVS AgEagle Aerial Systems Inc. Stock $uavs

2023 Q3 Form 10-Q Financial Statement

#000149315223028560 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UAVS
AgEagle Aerial Systems Inc. Stock $uavs